Literature DB >> 1634142

Inexpensive population screening for abnormal cells from the uterine cervix and valid results using the vaginal cytopipette.

S Fischer1.   

Abstract

Women who have not accepted an invitation by their own general practitioner to have a smear test, or for whom voluntary population screening projects are unavailable because of lack of public funds, may be at increased risk of malignant cervical changes. Such women may be offered self-testing by a cytopipette on the basis of the present analysis of abnormal cell counts and cell density on the cytological slides. As one link in a prophylactic study using the cytopipette, 107 women with abnormal cell findings were reinvited for simultaneous sampling by irrigation smear and by ordinary technique. The cytological findings indicate that the two methods are equal in recovery of abnormal epithelium, provided that the scanned quantity of cells is increased fourfold in the irrigation smear method, this quantity being distributed over two specimens each with double cell density and giving at least 1800 squamous epithelial cells per visual field (125:1) or a total of approximately 10(6) epithelial cells in each cytological specimen. Under these conditions the two sampling methods have the same predictive value.

Entities:  

Mesh:

Year:  1992        PMID: 1634142     DOI: 10.1016/0090-8258(92)90197-q

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control.

Authors:  E L Franco
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

2.  Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; L H Jaspars; F J Voorhorst; R H M Verheijen; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.